A multidisciplinary intervention to support return to work of individuals with breast cancer: a prospective feasibility study.

Support Care CancerSep 16, 2026 (epub)

Sara Paltrinieri, Luca Braglia, Francesca Bravi et al.

✦ AI-curated · Sources linked

In 30 seconds

This prospective feasibility study evaluated a multidisciplinary intervention aimed at supporting work reintegration for employed individuals with breast cancer facing work-related difficulties. Out of 85 individuals, 32 (37.6%) were eligible, with 50% accepting participation. By 12 months, 10 out of 11 participants (95% CI 58.7%-99.8%) achieved work reintegration, indicating the intervention's feasibility.

Key findings

  • 37.6% of participants met eligibility criteria for the study.
  • 50% of eligible participants accepted the invitation to participate.
  • At 12 months, 95% of participants achieved work reintegration.
  • Adherence to the intervention was high, peaking at 92.3% at 1 month.

Why it matters

Understanding the feasibility of multidisciplinary interventions can help clinicians design effective support systems for individuals with breast cancer, ultimately improving their work participation and quality of life.

Source

Published in Support Care Cancer. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.